April 15th, 2019

 Newsletter April 2019


ID-EPTRI 3rd General Assembly, 27-28 March 2019, Madrid: an update on the project and future perspectives

On 27-28 March 2019, the EPTRI (European Paediatric Translational Research Infrastructure) 3rd General Assembly meeting took place in Madrid at the Ministry of Health. The event was the occasion to take stock of the situation on the activities and the goals achieved in the first year of the project as well as the future perspectives and objectives of EPTRI, the European project, funded within H2020 Infradev-01-2017 call and coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) with the aim to design a new paediatric Research Infrastructure (RI), intended to accelerate paediatric drug development including most relevant technological innovations in research for children’s health.

Read more

18 March 2019: SPASD Workshop – Methodologies for an inclusive education: the course is ready

The Italian multiplier event, foreseen in the framework of the SPASD (Strengthening the Capacity of Professionals Working in Schools with Children and Young People with Autism Spectrum Disorder – ASD) project took place on 18 March 2019 at the University of Bari “A. Moro” and was focused on the “Innovative methodologies for an inclusive education”. SPASD is an international project funded within the European Programme Erasmus+  and arose from the willing to offer equal opportunities to children with ASD, as a main concern in all the countries involved in the project and also as an answer to the recent EU and national policies promoting equal possibilities in accessing education for all children and fostering the integration of children with disabilities into the general education system.

Read more

EMA: Regulatory information – adjusted fees for applications to EMA from 1 April 2019

General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.7% on 1 April 2019. Every year, the European Commission adopts a regulation adjusting the fees payable to the Agency with reference to the inflation rate in the European Union for the previous year. The 2018 inflation rate was 1.7%. Full details of the new fee levels are available in Commission Regulation (EU) No 2019/480 amending Council Regulation (EC) No 297/95, its implementing rules and the corresponding explanatory note on fees.

Read more

#wecare_ye: a new project for CVBF 

We are very pleased to announce that the #wecare_ye project, coordinated by CVBF and funded within the European Programme Erasmus+, started in January 2019 with the aim to foster youth active participation in the field of Health and Wellbeing and support actions for the promotion of youth groups exchange in Belgium, the Czech Republic, Greece and Romania, based on the model of what has been achieved with the first Italian and Albanian Young Persons Advisory Groups, respectively named KIDS Bari and KIDS Tirana.

Read more


April 2019, 17

EUCROF Webinar “Doing More with Data: Data Anonymisation and Pseudonymisation under the GDPR”
Registrations are still open for the new EUCROF webinar “Doing More with Data: Data Anonymisation and Pseudonymisation under the GDPR” that will take place on 17 April 2019. The webinar will describe pseudo-nymisation and anonymisation techniques, specifically for clinical trial data, and how these fit within the GDPR regulatory framework. 

Read more

May 2019, 16-17

The 2nd Kiev Clinical Research Forum
The 2nd Kiev Clinical Research Forum will take place on 16 – 17 May 2019 in Kiev under the patronage of EUCROF. Donato Bonifazi, Chief Executive Officer at Consorzio per Valutazioni Biologiche e Farmacologiche and chair of the EUCROF Events and Training Working Group will participate in the meeting as speaker.

Read more




Consorzio per Valutazioni Biologiche e Farmacologiche

I-70122 BARI Via Nicolò Putignani 178

You received this email because you are involved in the CVBF ACTIVITIES.

unsubscribe from this list    update subscription preferences

Newsletter service powered by Consorzio per Valutazioni Biologiche e Farmacologiche – [email protected]


About the Author: Flogert Dollani


By Published On: April 15th, 2019Categories: Newsletter0 Comments